Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n=
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n=
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1050 891
Bimekizumab 129 0
Brodalumab 508 0
Certolizumab 172 0
Efalizumab 35 0
Etanercept 311 70
Golimumab 25 0
Guselkumab 1207 0
Infliximab 102 1
Ixekizumab 795 0
Risankizumab 893 0
Secukinumab 1749 0
Tildrakizumab 922 0
Ustekinumab 754 0
Apremilast 679 0
Ciclosporin 402 0
Fumaderm® 2689 0
Skilarence® 2799 0
Methotrexat 3895 0
Tofacitinib 2 0
other systemics 354 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n=
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n=
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers